All In Biotech

Drug Trial Radar · NCT00205777

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

Fracture Incidence Reduction And Safety Of TSE-424 (Bazedoxifene Acetate) Compared To Placebo And Raloxifene In Osteoporotic Postmenopausal Women

Last checked: Nov 20, 2026Latest source record: Apr 10, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 7,609 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

7,609

Actual

Start

Dec 2001

Primary completion

Sep 2010

Study completion Sep 2010

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Sep 20, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Single group
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
Female only, from 55 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether bazedoxifene acetate is safe and effective in the treatment of osteoporosis in postmenopausal women.

Conditions

  • Osteoporosis

Interventions

  • Bazedoxifene AcetateDrug

    BZA 20mg, daily, oral

  • PlaceboOther

    Placebo, daily, oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With New Vertebral Fractures Through Month 36Time frame: Baseline through Month 36
  2. Percentage of Participants With New Vertebral Fractures Through Month 60Time frame: Baseline through Month 60
  3. Percentage of Participants With New Vertebral Fractures Through Month 84Time frame: Baseline through Month 84

Locations

375 sites in 30 countries. Site status is shown where the registry gives one.

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Birmingham, Alabama

  • Pfizer Investigational Site

    Huntsville, Alabama

  • Pfizer Investigational Site

    Mobile, Alabama

  • Pfizer Investigational Site

    Glendale, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Scottsdale, Arizona

  • Pfizer Investigational Site

    Scottsdale, Arizona

  • Pfizer Investigational Site

    Anaheim, California

  • Pfizer Investigational Site

    Berkeley, California

  • Pfizer Investigational Site

    Beverly Hills, California

  • Pfizer Investigational Site

    Fresno, California

  • Pfizer Investigational Site

    Fresno, California

  • Pfizer Investigational Site

    La Jolla, California

  • Pfizer Investigational Site

    Oakland, California

  • Pfizer Investigational Site

    Palm Desert, California

  • Pfizer Investigational Site

    Palm Springs, California

  • Pfizer Investigational Site

    Palm Springs, California

  • Pfizer Investigational Site

    Palm Springs, California

  • Pfizer Investigational Site

    Rancho Mirage, California

  • Pfizer Investigational Site

    Sacramento, California

  • Pfizer Investigational Site

    Sacramento, California

  • Pfizer Investigational Site

    Sacramento, California

  • Pfizer Investigational Site

    San Diego, California

  • Pfizer Investigational Site

    San Diego, California

  • Pfizer Investigational Site

    Upland, California

  • Pfizer Investigational Site

    Whittier, California

  • Pfizer Investigational Site

    Lakewood, Colorado

  • Pfizer Investigational Site

    Longmont, Colorado

  • Pfizer Investigational Site

    Wheat Ridge, Colorado

  • Pfizer Investigational Site

    Bridgeport, Connecticut

  • Pfizer Investigational Site

    Hamden, Connecticut

Showing 40 of 375 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.